Search

everythinglearnresearchcommunity

for

Search:↓

JSLE patients often have more hormone and metabolism issues, so regular check-ups and preventing obesity can help.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Diagnosing both systemic lupus and hemoglobinopathy is challenging due to overlapping symptoms.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Most lupus patients in the study experienced hair loss, which greatly affected their mental and social well-being.

Early detection and tailored treatment of lupus nephritis are crucial to prevent kidney damage.

Low free thyroxine (FT4) is common in young lupus patients and needs quick diagnosis and treatment.

A woman with lupus had rare severe symptoms but improved with treatment.

Many patients with cutaneous lupus erythematosus experience hair loss and nail problems, which are important for diagnosis and treatment.

Natural plant compounds may offer safer COVID-19 treatments with fewer side effects.

Most pregnancies with SLE resulted in intrauterine growth restriction (IUGR).

Patients with Discoid Lupus Erythematosus have lower vitamin D and antioxidant levels and higher oxidative stress.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Progranulin overexpression leads to shorter, thinner hair and increased cell death in mouse hair follicles.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

The search scheme SMRI is faster and more secure for retrieving encrypted data from the cloud.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

KSR1 is crucial for certain skin tumor formation and could be a cancer therapy target.

The 2012 SLICC criteria provide an updated method for classifying Systemic Lupus Erythematosus.

A severe virus outbreak in yaks on the Qinghai-Tibet Plateau caused high death rates and requires targeted control measures.

The engineered yeast strain BLYAS can quickly and sensitively detect androgenic chemicals.

New tools and criteria have been developed to better assess and treat pediatric lupus.

SLE in Iraqi patients often involves hair loss and photosensitivity, with common treatments being corticosteroids and immunosuppressants.

Non-scarring hair loss in lupus patients often responds well to treatment and doesn't lead to scarring.

A woman with lupus also developed a severe skin condition linked to a genetic factor.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.